16 completed, 4 not yet recruiting, 4 unknown, 2 terminated. 9 Not applicable, 4 Phase 1, 3 Phase 2, 3 Phase 3, 1 Early Phase 1.
Follow Chikungunya: new trials by email Literature Review of Chikungunya trials Research Report on Chikungunya
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trial to Evaluate the Immunogenicity and Safety of the Co-administration of Live Attenuated Dengue and Chikungunya Vaccines Compared to Separate Administration in Adults Aged 18 to 59 Years. DENGUE: Dengue 1,2,3,4 (attenuated) vaccine CHIKUNGUNYA: Chikungunya (CHIKV) live attenuated vaccine (VLA1555), DENGUE: Dengue 1,2,3,4 (attenuated) vaccine, Chikungunya (CHIKV) live attenuated vaccine (VLA1555) - Dengue, Chikungunya | Phase 3 | Not yet recruiting | Butantan Institute | 900 | 2027-03-31 | 2026-07-16 |
| A Phase I Study of PepGNP-ChikV in Healthy Volunteers PepGNP-ChikV, Placebo - Chikungunya, Chikungunya Fever | Early Phase 1 | Not yet recruiting | Gylden Pharma Ltd | 40 | 2026-08-03 | 2026-04-29 |
| Effects Of A Rehabilitation Protocol On Muscle Strength, Muscle Fatigue And Postural Control In Post-Dengue And Chikungunya Patients Exercise - Dengue, Chikungunya | Not applicable | Not yet recruiting | Universidade do Estado do Pará | 54 | 2026-07-01 | 2026-05-26 |
| Using Digital Technology for the Prevention of Aedes-Borne Diseases in Colombian Communities Full intervention, Partial intervention - Dengue, Zika | Not applicable | Completed | University of Freiburg | 900 | 2026-03-26 | 2026-04-08 |
| Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective Dengue, Chikungunya | Recruiting | Institut Pasteur du Cambodge | 10000 | 2025-12-18 | 2026-01-22 | |
| Prospective Clinical Registry for Evaluation of Exanthematous Infections and Coinfections Exanthema, Dengue Fever | Not yet recruiting | Hospital Israelita Albert Einstein | 830 | 2025-09-01 | 2025-08-08 | |
| Trial of an Inactivated Chikungunya Virus Vaccine HydroVax-005 CHIKV, Placebo - Chikungunya Fever, Chikungunya Virus | Phase 1 | Completed | Najit Technologies, Inc. | 48 | 2024-11-04 | 2026-03-19 |
| Testing Combined IIT-SIT to Control Mosquito-Borne Diseases At Scale Wolbachia induced incompatible mating, Standard traditional chemical mosquito control - Dengue, Zika | Not applicable | Terminated | Michigan State University | 15243 | 2024-05-28 | 2026-03-19 |
| Impact of Differential and Systematic Diagnosis of Dengue, Chikungunya and Malaria on Patient Management and Antibiotic Use in West Africa VIDAS® Dengue Antigen NS1, VIDAS® Anti-Dengue IgM, VIDAS® Anti-Dengue IgG, VIDAS® Anti-Chikungunya IgM and VIDAS® Anti-Chikungunya IgG, Standard of care practices - Dengue, Chikungunya | Not applicable | Completed | BioMérieux | 804 | 2023-06-01 | 2025-02-11 |
| Post-Chikungunya Rheumatism - Rheumatology Follow-up of Patients After 15 Years 15 years Follow-up group - Chikungunya | Completed | Centre Hospitalier Universitaire de la Réunion | 152 | 2023-02-20 | 2026-03-04 | |
| Population Immunity AgaiNst mosquitO-borne Diseases in Vanuatu Blood collection - Arbovirus Disease, Zika | Not applicable | Completed | Institut Pasteur | 1122 | 2022-10-17 | 2024-05-23 |
| A Multicenter Study to Evaluate Safety and Immunogenicity of a Live-attenuated Chikungunya Vaccine in Adolescents Active, Placebo - Chikungunya | Phase 3 | Completed | Butantan Institute | 754 | 2022-02-14 | 2026-06-04 |
| Seamless Controlled Trial To Evaluate Safety And Immunogenicity of Chikungunya Vaccine in LatinAmerica and Asia BBV87 Chikungunya vaccine, Normal Saline - Chikungunya | Phase 2 / Phase 3 | Terminated | International Vaccine Institute | 3210 | 2021-08-01 | 2025-06-22 |
| Baromètre Santé Adulte 2021-2022 Blood sample - Diabetes, Hypercholesterolemia | Not applicable | Suspended | Agence Sanitaire et Sociale de Nouvelle Calédonie | 5471 | 2021-07-26 | 2022-02-01 |
| Virological and Immunological Determinants of Arbovirus Infection in New Caledonia Blood sample collection - Arbovirus Infections, Zika | Not applicable | Unknown | Institut Pasteur | 250 | 2021-02-15 | 2024-05-23 |
| Sylvatic Transmission of Zika, Dengue, and Chikungunya Viruses in Thailand and Cambodia Dengue Fever, Zika | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 300 | 2021-02-08 | 2024-04-26 | |
| Infection Tracking in Travellers. The Project Aims to Identify Profiles of Travel-associated Illness and to Follow up on Long-term Sequelae of Arboviral Infections and Malaria Observational study - Travel-Related Illness, Malaria | Unknown | Patricia Schlagenhauf | 10000 | 2021-01-30 | 2020-12-17 | |
| Quantifying the Epidemiological Impact of Targeted Indoor Residual Spraying on Aedes-borne Diseases Targeted Indoor Residual Spraying (TIRS) - Aedes-borne Diseases, Dengue | Not applicable | Completed | Emory University | 4461 | 2020-11-03 | 2025-09-18 |
| Research Study to Assess New Chikungunya and Zika Vaccines in Healthy Adults in Mexico. CHIK low dose, CHIK mid dose, CHIK high dose - Chikungunya, Zika | Phase 1 | Completed | University of Oxford | 120 | 2020-10-23 | 2022-03-23 |
| Genetic Evolution of Arboviruses in New Caledonia Between 1995 and 2024 and Impact of Wolbachia Arbovirus Infections, Dengue | Unknown | Institut Pasteur | 600 | 2020-07-17 | 2024-05-23 |
Showing 20 of 28. Sign in to see all of them.
Chikungunya Fever (28) · Dengue (17) · Zika Virus Infection (14) · Malaria (5) · Arbovirus Infections (2) · Communicable Diseases (2) · Leishmaniasis (2) · Measles (2) · Mosquito-Borne Diseases (2) · Ross River Virus Infection (2) · Rubella (2) · Severe Acute Respiratory Syndrome (2) · Vector Borne Diseases (2) · Adenoviridae Infections (1) · Arenaviridae Infections (1)
Alphavirus Infections (28) · Infections (28) · RNA Virus Infections (28) · Togaviridae Infections (28) · Virus Diseases (28) · Arbovirus Infections (26) · Mosquito-Borne Diseases (26) · Vector Borne Diseases (26) · Flaviviridae Infections (18) · Flavivirus Infections (18) · Hemorrhagic Fevers, Viral (17) · Pathological Conditions, Signs and Symptoms (7) · Parasitic Diseases (5) · Pathologic Processes (5) · Protozoan Infections (5)
Blood Specimen Collection (3) · Exercise (2) · Arthrocentesis (1) · Measles-Mumps-Rubella Vaccine (1) · Observation (1) · Phlebotomy (1) · Saline Solution (1) · Vaccines (1) · Vaccines, Attenuated (1)
Institut Pasteur (3) · Butantan Institute (2) · National Institute of Allergy and Infectious Diseases (NIAID) (2) · Agence Sanitaire et Sociale de Nouvelle Calédonie (1) · Bavarian Nordic (1) · Bharat Biotech International Limited (1) · BioMérieux (1) · Centre Hospitalier Universitaire de la Réunion (1) · Emory University (1) · George Washington University (1) · Gylden Pharma Ltd (1) · Hospital Israelita Albert Einstein (1) · Institut Pasteur du Cambodge (1) · International Vaccine Institute (1) · Mexican Emerging Infectious Diseases Clinical Research Network (1)
Mexico (4) · United States (4) · Brazil (3) · Cambodia (2) · Colombia (2) · France (2) · New Caledonia (2) · Reunion (2) · Burkina Faso (1) · Costa Rica (1) · Côte d’Ivoire (1) · French Guiana (1) · Germany (1) · Guadeloupe (1) · Guatemala (1)
Myrielle Dupont-Rouzeyrol, PhD (3) · Aileen Y Chang, MD MSPH (1) · Andre Cabie, MD (1) · Christina Yek, M.D. (1) · Claude Flamand, Ph.D. (1) · Clemente Diaz, MD (1) · Fernanda C Boulos, MD, MSc (1) · Gonzalo Vazquez Professor Prokopec, PhD (1) · Gonzalo Vazquez Prokopec, MD (1) · Guillermo Ruiz-Palacios (1) · James McCarty, MD (1) · Krishna Mohan, PHD (1) · Matthew J Memoli, M.D. (1) · Nina Wressnigg (1)
PMID 32497524, PMID 29266856, PMID 31672665, PMID 32163420, PMID 32220283, PMID 33422034, PMID 33686914, PMID 33828518, PMID 34454432, PMID 37068115, PMID 37254133, PMID 37321235, PMID 38294972, PMID 38794811, PMID 39067885, PMID 39116904, PMID 39243794, PMID 39255380, PMID 39543943, PMID 39954701, PMID 41061233, PMID 41260318, PMID 41380703, PMID 42552527
U01AI148069 (1), U44AI152995 (1)